Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Italy
Clinical trial register · Italy

Clinical Trials in Italy

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 76 Rome 72 Naples 46 Genoa 26 Bologna 20
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS363 IRCCS Azienda Ospedaliero-Universitaria di Bologna274 AstraZeneca180 IRCCS San Raffaele156 Novartis Pharmaceuticals132 Fondazione IRCCS Policlinico San Matteo di Pavia120 Merck Sharp & Dohme LLC116 Istituto Ortopedico Rizzoli108 Hoffmann-La Roche106 Janssen Research & Development, LLC82 AbbVie77 Bristol-Myers Squibb74 European Institute of Oncology74 Eli Lilly and Company74 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico65 Sanofi63 Istituti Clinici Scientifici Maugeri SpA58 Pfizer56 GlaxoSmithKline48 Fondazione Don Carlo Gnocchi ETS48 Istituto Clinico Humanitas47 Mario Negri Institute for Pharmacological Research46 Istituto Auxologico Italiano45 IRCCS Policlinico S. Donato45 I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio45 Amgen43 Meyer Children's Hospital IRCCS43 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano41 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta40 IRCCS Eugenio Medea39 University of Roma La Sapienza37 National Cancer Institute, Naples36 Regina Elena Cancer Institute35 Takeda35 Azienda USL Reggio Emilia - IRCCS35 Novo Nordisk A/S35 Federico II University34 Boehringer Ingelheim34 Fondazione Italiana Linfomi - ETS33 University of Milano Bicocca32 Incyte Corporation31 Bayer31 University of Padova30 Istituto Giannina Gaslini29 Niguarda Hospital29 Università Vita-Salute San Raffaele29 Daiichi Sankyo29 Abbott Medical Devices28 European Organisation for Research and Treatment of Cancer - EORTC26 Centro di Riferimento Oncologico - Aviano25 University Hospital of Ferrara25 argenx25 University of Pavia25 Alexion Pharmaceuticals, Inc.24 IRCCS Centro Neurolesi Bonino Pulejo24 Regeneron Pharmaceuticals24 University of Milan23 IRCCS San Raffaele Roma22 Boston Scientific Corporation22 Centro Cardiologico Monzino22 BeOne Medicines22 University of Palermo22 Gruppo Italiano Malattie EMatologiche dell'Adulto22 Universita di Verona22 Gilead Sciences22 University of Pisa21 University of Bologna20 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS19 Catholic University of the Sacred Heart19 Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria19 IRCCS Fondazione Stella Maris18 University of Turin, Italy17 Fondazione Policlinico Universitario Campus Bio-Medico17 University of Campania Luigi Vanvitelli17 Fondazione del Piemonte per l'Oncologia17 Celgene17 Genmab17 IRCCS Sacro Cuore Don Calabria di Negrar17 Istituto Oncologico Veneto IRCCS17 Gruppo Oncologico del Nord-Ovest16 Istituto per la Ricerca e l'Innovazione Biomedica16 Azienda Ospedaliera Universitaria Integrata Verona15 I.R.C.C.S. Fondazione Santa Lucia15 W.L.Gore & Associates15 University of Rome Tor Vergata15 University of Florence15 Azienda Ospedaliero-Universitaria Careggi15 University of Bari14 Azienda Ospedaliero-Universitaria di Parma14 University Hospital, Basel, Switzerland13 Biogen13 IRCCS National Neurological Institute "C. Mondino" Foundation12 IRCCS Ospedale San Raffaele12 Scientific Institute San Raffaele12 Ionis Pharmaceuticals, Inc.12 Gruppo Oncologico Italiano di Ricerca Clinica12 IRCCS Centro San Giovanni di Dio Fatebenefratelli12 UCB Biopharma SRL12 Casa di Cura Dott. Pederzoli12 University of Modena and Reggio Emilia12 Istituto Nazionale di Ricovero e Cura per Anziani12 Seagen, a wholly owned subsidiary of Pfizer12 Liaquat University of Medical & Health Sciences12 Vertex Pharmaceuticals Incorporated11 Astellas Pharma Global Development, Inc.11 Azienda Usl di Bologna11 Stefano Zaffagnini11 Exelixis11 BioMarin Pharmaceutical11 Acerta Pharma BV11 Ipsen11 Azienda Ospedaliero Universitaria Maggiore della Carita10 International Extranodal Lymphoma Study Group (IELSG)10 Philogen S.p.A.10 Azienda Ospedaliero-Universitaria di Modena10 University of Cagliari10 Bambino Gesù Hospital and Research Institute10 G. d'Annunzio University10 Genentech, Inc.10 ETOP IBCSG Partners Foundation10 Italian Sarcoma Group10 Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari10 Azienda Ospedaliera di Padova9 IRCCS Burlo Garofolo9 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia9 Maria Cecilia Hospital9 Alnylam Pharmaceuticals9 BioNTech SE9 European Myeloma Network B.V.8 Medtronic8 Campus Bio-Medico University8 Swedish Orphan Biovitrum8 University of Catania8 EMD Serono Research & Development Institute, Inc.8 ASST Fatebenefratelli Sacco8 Taiho Oncology, Inc.8 Neuromed IRCCS8 Revolution Medicines, Inc.8 Università degli Studi di Ferrara8 University of Parma7 Jazz Pharmaceuticals7 Institut de Recherches Internationales Servier7 IRCCS San Camillo, Venezia, Italy7 University of Bari Aldo Moro7 Zimmer Biomet7 University of Siena7 UNICANCER7 Loxo Oncology, Inc.7 Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis7 Mirati Therapeutics Inc.7 ViiV Healthcare7 FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS7 Fondazione Ricerca Traslazionale7 Università degli Studi di Sassari6 Sarepta Therapeutics, Inc.6 University of Oxford6 University of Salerno6 Zenas BioPharma (USA), LLC6 University of L'Aquila6 A.O.U. Città della Salute e della Scienza6 Pierre Fabre Medicament6 H. Lundbeck A/S6 Ospedale San Raffaele6 International Piezosurgery Academy6 Ospedale Policlinico San Martino6 Karyopharm Therapeutics Inc6 Fondazione G.B. Bietti, IRCCS6 Ciceri Fabio6 Azienda Ospedaliero, Universitaria Pisana6 RECORDATI GROUP6 CNAO National Center of Oncological Hadrontherapy6 Medtronic Cardiovascular6 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)6 University of Foggia6 Mirum Pharmaceuticals, Inc.6 Princess Maxima Center for Pediatric Oncology5 Agios Pharmaceuticals, Inc.5 Istituto Scientifico Italiano Colonna Vertebrale5 Edwards Lifesciences5 Stemline Therapeutics, Inc.5 Luca Sangiorgi5 Medacta International SA5 Alfasigma S.p.A.5 San Luigi Gonzaga Hospital5 Deciphera Pharmaceuticals, LLC5 Italfarmaco5 MedSIR5 The Mediterranean Institute for Transplantation and Advanced Specialized Therapies5 Universitätsklinikum Hamburg-Eppendorf5 IFOM ETS - The AIRC Institute of Molecular Oncology5 Gustave Roussy, Cancer Campus, Grand Paris5 Immunovant Sciences GmbH5 Papa Giovanni XXIII Hospital5 Population Health Research Institute5 Hospital Universitari Vall d'Hebron Research Institute5 Immunocore Ltd5 IRCCS SYNLAB SDN5 Associazione Italiana per lo Studio del Pancreas5 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company5 Costantino Errani5 University of Udine5 Consorzio Oncotech5 Octapharma5 Ente Ospedaliero Ospedali Galliera5 Syndax Pharmaceuticals4 Kura Oncology, Inc.4 LMU Klinikum4 Insel Gruppe AG, University Hospital Bern4 Summit Therapeutics4 Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse4 UMC Utrecht4 Cytokinetics4 Fondazione EMN Italy Onlus4 S. Andrea Hospital4 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company4 Tethis S.p.A.4 Ospedali Riuniti Trieste4 Alkermes, Inc.4 ARCAGY/ GINECO GROUP4 San Raffaele University4 Blueprint Medicines Corporation4 University of Calabria4 Ascentage Pharma Group Inc.4 Xenon Pharmaceuticals Inc.4 Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano4 Eisai Inc.4 Institute of Mountain Emergency Medicine4 Heart Care Foundation4 Medtronic Cardiac Ablation Solutions4 Teva Branded Pharmaceutical Products R&D LLC4 Crinetics Pharmaceuticals Inc.4 Università degli Studi dell'Insubria4 F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore4 Neurocrine Biosciences4 Smith & Nephew, Inc.4 Kite, A Gilead Company4 Fondazione IRCCS San Gerardo dei Tintori4 Fondazione Telethon4 MedImmune LLC4 Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna4 Tesaro, Inc.4 ACADIA Pharmaceuticals Inc.4 Azienda Unita Sanitaria Locale di Piacenza4 CatalYm GmbH4 Policlinico Hospital4 Biotronik SE & Co. KG4 Washington University School of Medicine4 Genzyme, a Sanofi Company4 Oasi Research Institute-IRCCS4 University Hospital Padova4 Rede Optimus Hospitalar SA4 CSL Behring4 Servier Bio-Innovation LLC4 iOnctura4 Medical University of Vienna4 Universita degli Studi di Genova4 MSD Italia S.r.l.3 Radboud University Medical Center3 Università degli Studi del Piemonte Orientale Amedeo Avogadro3 Amicus Therapeutics3 Charite University, Berlin, Germany3 ICIM International S.r.l.3 LEO Pharma3 Ultragenyx Pharmaceutical Inc3 GE Healthcare3 Chinese Academy of Sciences3 Azienda Ospedaliero Universitaria di Sassari3 Weill Medical College of Cornell University3 Innate srl3 Chiesi Farmaceutici S.p.A.3 Università degli Studi di Trento3 University Hospital, Ghent3 Travere Therapeutics, Inc.3 United Therapeutics3 Associazione Italiana Ematologia Oncologia Pediatrica3 Università degli Studi 'G. d'Annunzio' Chieti e Pescara3 Longboard Pharmaceuticals3 University of Trieste3 Terumo Europe N.V.3 ASL Lecce3 Azienda Ospedaliero, Universitaria Ospedali Riuniti3 Enliven Therapeutics3 Entrada Therapeutics, Inc.3 Orchard Therapeutics3 Corcept Therapeutics3 Azafaros B.V.3 Leiden University Medical Center3 Azienda Sanitaria Locale CN2 Alba-Bra3 Abivax S.A.3 Alentis Therapeutics AG3 Denali Therapeutics Inc.3 Avidity Biosciences, Inc.3 BicycleTx Limited3 Fondazione Ricerca e Innovazione Cardiovascolare ETS3 Copenhagen University Hospital, Rigshospitalet3 European Association of Urology Research Foundation3 Dr. Inge Winter3 Dyne Therapeutics3 M.A. Med Alliance S.A.3 Nuvalent Inc.3 Wooshin Labottach Co., Ltd.3 Università degli Studi di Brescia3 Careggi Hospital3 Biotronik AG3 Santa Chiara Hospital3 Technische Universität Dresden3 IBSA Farmaceutici Italia Srl3 Limacorporate S.p.a3 Casa di Cura IGEA3 Assistance Publique - Hôpitaux de Paris3 University of Alberta3 Pharvaris Netherlands B.V.3 Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato3 University Health Network, Toronto3 ArriVent BioPharma, Inc.3 Fondazione Matilde Tettamanti Menotti De Marchi Onlus3 Società Italiana di Allergologia, Asma e Immunologia Clinica3 IDEAYA Biosciences3 Abiomed Inc.3 Università Politecnica delle Marche3 San Giovanni di Dio Hospital3 Humanitas Clinical and Research Center3 Cullinan Therapeutics Inc.3 Celldex Therapeutics3 Centro Universitario Ricerca Interdipartimentale Attivita' Motoria3 University College Dublin3 Dianthus Therapeutics3 Kartos Therapeutics, Inc.3 ADARx Pharmaceuticals, Inc.3 Relay Therapeutics, Inc.3 Janssen Pharmaceutica N.V., Belgium3 Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)3 AUSL Romagna Rimini3 AOP Orphan Pharmaceuticals AG3 Stichting Hemato-Oncologie voor Volwassenen Nederland3 ASST Sette Laghi3 Cogent Biosciences, Inc.3 Lo.Li.Pharma s.r.l3 Fondazione Melanoma Onlus3 Società Italiana Talassemie ed Emoglobinopatie3 Karolinska Institutet3 Janssen-Cilag Ltd.3 Azienda Ospedaliera "Sant'Andrea"3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 Biosense Webster, Inc.3 Marche Region Regional Health Agency3 Euresist Network GEIE3 Fidia Farmaceutici s.p.a.3 Cardarelli Hospital3 Francesco De Cobelli3 Vascutek Ltd.3 Duke University3 GRIN Therapeutics, Inc.3 Inhibrx Biosciences, Inc3 Azienda ULSS 8 Berica3 Regione del Veneto - AULSS n. 7 Pedemontana3 Massachusetts General Hospital3 Stichting European Myeloma Network3 CoreAalst BV3 University Hospital, Antwerp3 Fundación Pública Andaluza para la gestión de la Investigación en Sevilla2 Uppsala University2 Ethicon, Inc.2 NS Pharma, Inc.2 Olema Pharmaceuticals, Inc.2 Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva2 City of Hope Medical Center2 Miltenyi Biomedicine GmbH2 Umbria Bioengineering Technologies2 Dizal Pharmaceuticals2 Institut für Pharmakologie und Präventive Medizin2 Mayo Clinic2 University of Iowa2 Azienda Socio Sanitaria Territoriale di Lodi2 Fondazione Sandro Pitigliani2 Mater Olbia Hospital2 Penumbra Inc.2 Castagna Antonella2 Iovance Biotherapeutics, Inc.2 Aristotle University Of Thessaloniki2 Scholar Rock, Inc.2 University of Molise2 Grupo Espanol de Investigacion en Sarcomas2 Fondazione Luigi Villa2 University Medical Center Groningen2 Jaeb Center for Health Research2 Aziende Chimiche Riunite Angelini Francesco S.p.A2 Celcuity Inc2 Medtronic Cardiac Surgery2 EndoCore Lab s.r.l.2 Taewoong Medical Co., Ltd.2 Nurix Therapeutics, Inc.2 Vesalio2 Paolo Ghia2 Gruppo Italiano Trapianto di Midollo Osseo2 Azienda Sanitaria Universitaria Integrata del Trentino2 Spyre Therapeutics, Inc.2 Lupin Ltd.2 Casa Sollievo della Sofferenza IRCCS2 Otsuka Pharmaceutical Development & Commercialization, Inc.2 GLSMED Learning Health S.A.2 Curis, Inc.2 Guna S.p.a2 Azienda Ospedaliera di Bolzano2 University of Pennsylvania2 Glycomine, Inc.2 Albireo, an Ipsen Company2 Societa Italiana di Pneumologia2 PedAL BCU, LLC2 Ad scientiam2 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc2 Azienda Ospedaliera di Perugia2 Fondazione Italiana Sindromi Mielodisplastiche-ETS2 Buzzi Children's Hospital2 AnaptysBio, Inc.2 Lifetech Scientific (Shenzhen) Co., Ltd.2 University Of Perugia2 Arrowhead Pharmaceuticals2 Andrea DeCensi2 Kumquat Biosciences Inc.2 Verastem, Inc.2 University Magna Graecia2 VectivBio AG2 RHEACELL GmbH & Co. KG2 Occlutech International AB2 University of Messina2 Amerigo Giudice2 424 General Military Hospital2 Dompé Farmaceutici S.p.A2 Alfonso Magliacano2 Actelion2 ML Bio Solutions, Inc.2 LeMaitre Vascular2 Delcath Systems Inc.2 Momo Fertilife2 Avalyn Pharma Inc.2 Fondazione Italiana Sclerosi Multipla2 ITM Solucin GmbH2 Nobel Biocare2 University Hospital Muenster2 European Clinical Research Alliance for Infectious Diseases (ECRAID)2 ESI2 Fundación EPIC2 Carmen Fava2 Applied Biology, Inc.2 ModernaTX, Inc.2 Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2 Colorado Prevention Center2 Genetix Biotherapeutics Inc.2 Vir Biotechnology, Inc.2 Eidos Therapeutics, a BridgeBio company2 Turning Point Therapeutics, Inc.2 Ono Pharmaceutical Co., Ltd.2 Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna2 VisionCare, Inc.2 Centro Medico Teknon2 Quovadis Associazione2 Geron Corporation2 M.D. Anderson Cancer Center2 Maastricht University Medical Center2 Fondazione GISE Onlus2 Istituto Superiore di Sanità2 Heidelberg University2 Memorial Sloan Kettering Cancer Center2 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy2 Immune Oncology Research Institute2 Artivion Inc.2 Hansa Biopharma AB2 JCR Pharmaceuticals Co., Ltd.2 United Pharmaceuticals2 Hospital of Macerata2 medac GmbH2 University of Catanzaro2 Giovanna Zamboni2 Société des Produits Nestlé (SPN)2 Biohaven Therapeutics Ltd.2 Astria Therapeutics, Inc.2 Shanghai Chest Hospital2 Mario Stirpe2 InSightec2 Madrigal Pharmaceuticals, Inc.2 Centessa Pharmaceuticals (UK) Limited2 SystImmune Inc.2 Canadian Cancer Trials Group2 Andrés José Maria Ferreri2 Medipol University2 Children's Hospital of Philadelphia2 Basilea Pharmaceutica2 Società Italiana di Medicina Interna2 Casa di Cura San Raffaele Cassino2 Erasmus Medical Center2 Italian Society for Rheumatology2 USWM CT, LLC2 Consorzio Futuro in Ricerca2 Catholic University, Italy2 Region Skane2 Paolo Manzoni Study Group2 Dentsply Sirona Implants and Consumables2 Iperboreal Pharma Srl2 Promoitalia Group Spa2 Sumitomo Pharma America, Inc.2 mAbxience Research S.L.2 CUTISS AG2 Association for Innovation and Biomedical Research on Light and Image2 Calcilytix Therapeutics, Inc., a BridgeBio company2 Children's Oncology Group2 EyeBiotech Ltd.2 Meril Life Sciences Pvt. Ltd.2 Chugai Pharmaceutical2 Corbus Pharmaceuticals Inc.2 Azienda Sanitaria dell'Alto Adige2 Kardigan, Inc.2 Biobizkaia Health Research Institute2 Devintec Sagl2 University College, London2 Groupe Francophone des Myelodysplasies2 ADC Therapeutics S.A.2 AtriCure, Inc.2 Montreal Heart Institute2 Xeltis2 Fondazione Oncotech2 Guerbet2 Merz Therapeutics GmbH2 ARNAS Civico Di Cristina Benfratelli Hospital2 McGill University Health Centre/Research Institute of the McGill University Health Centre2 Pharming Technologies B.V.2 Mastelli S.r.l2 Shionogi2 Alliance Foundation Trials, LLC.2 Azienda Sanitaria Ospedaliera2 Fondazione Poliambulanza Istituto Ospedaliero2 Prilenia2 McMaster University2 Prof. Massimo Filippi2 University of Kiel2 Virginia Commonwealth University2 Murdoch Childrens Research Institute2 Fadoi Foundation, Italy2 European Foundation for Study of Chronic Liver Failure2 Unity Health Toronto2 Maastricht University2 Akero Therapeutics, Inc2 Rovere Querini Patrizia2 Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia2 Eikon Therapeutics2 University Hospital Tuebingen2 University of Leeds2 Ceric Sàrl2 Ataxia Study Group2 MicroPort CRM2 University of Bergamo2 A.O. Ospedale Papa Giovanni XXIII2 Laboratoires Thea2 Rocket Pharmaceuticals Inc.2 Ascendis Pharma A/S2 Arcus Biosciences, Inc.2 University of Rome Foro Italico2 Insmed Incorporated2 Cook Research Incorporated2 Kiniksa Pharmaceuticals International, plc2 NeuroDerm Ltd.2 Alimentiv Inc.2 University Hospital, Geneva2 Hannover Medical School2 ISTITUTO FARMOCHIMICO FITOTERAPICO: EPO SRL2 Aarhus University Hospital Skejby2 Kedrion S.p.A.2 Centro per la Lotta Contro l'Infarto - Fondazione Onlus2 Praxis Precision Medicines2 NovoCure GmbH2 Servier Affaires Médicales2 Region Örebro County2 Santen SAS2 Health and Happiness Research Limited1 Oncoinvent Solutions AS1 Ente Ospedaliero Cantonale, Bellinzona1 Panbela Therapeutics, Inc.1 De Sire Alessandro1 Thomas Riva1 OSE Immunotherapeutics1 Indiana Hemophilia &Thrombosis Center, Inc.1 Aesculap AG1 Yale University1 Azienda Socio Sanitaria della Brianza1 enGene, Inc.1 Theravance Biopharma1 EuroBloodNet Association1 MeiraGTx Ocular UK Ltd1 Universitat Internacional de Catalunya1 Sophia Genetics SAS1 FCRE (Foundation for Cardiovascular Research and Education)1 Politecnico di Milano1 Azienda Sanitaria Locale BT1 SECRETO Study Consortium1 Colgate Palmolive1 ECOG-ACRIN Cancer Research Group1 Policlinico Gaspare Rodolico - San Marco Catania1 Fatebenefratelli Hospital1 Scienceforbrain, UAB1 Galecto Biotech AB1 Giulio Zucchelli1 Microvention-Terumo, Inc.1 PharmaMar1 Xinnate AB1 Erasme University Hospital1 Merz Pharmaceuticals GmbH1 Biogem s.c.ar.l.1 Casa di Cura Privata 'Malzoni - Villa dei Platani' S.P.A.1 Diagram B.V.1 VZW Cardiovascular Research Center Aalst1 Ellipses Pharma1 Matteo Tonna1 Windtree Therapeutics1 Translumina Therapeutics Pvt Ltd.1 Paracelsus Medical University1 Federation Francophone de Cancerologie Digestive1 Spark Therapeutics, Inc.1 University Hospital, Udine, Italy1 Dren Bio1 Indena S.p.A1 University of Birmingham1 Chiara Lanzani1 Bordeaux Colorectal Institute Academy1 European Research Initiative on CLL1 Maurizio Tonetti1 German Cancer Research Center1 Balt Extrusion1 Almirall, S.A.1 Beyond Batten Disease Foundation1 Fundació d'investigació Sanitària de les Illes Balears1 Medical University of Graz1 The Lymphoma Academic Research Organisation1 Arianna Anticoagulazione Foundation1 ABX advanced biochemical compounds GmbH1 Assembly Biosciences1 Intra-Cellular Therapies, Inc.1 Koite Health Oy1 Pierachille Santus, MD, PhD1 ETH Zurich1 Mi Chen1 ASST Ovest Milanese1 SynOx Therapeutics Limited1 Metagenics, Inc.1 Grupo Espanol de Tumores Neuroendocrinos1 Aimmune Nestlé Health Science US R&D, LLC1 TWi Biotechnology, Inc.1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Clinica Mediterranea1 Aikaterini Karaivazoglou1 Ernesto Losavio1 D3 Bio (Wuxi) Co., Ltd1 Anna Erenbourg1 Abbisko Therapeutics Co, Ltd1 BioGaia AB1 MicroPort Orthopedics Inc.1 Genespire Srl1 Alpha Tau Medical LTD.1 Epygenix1 QualiMed Innovative Medizinprodukte GmbH1 Aelis Farma1 Ospedale degli Infermi di Biella1 Pharmacyclics Switzerland GmbH1 Edgewise Therapeutics, Inc.1 Fondazione Toscana Gabriele Monasterio1 Heidelberg Engineering GmbH1 Boston University1 Ospedale Santa Maria Goretti1 Universitaire Ziekenhuizen KU Leuven1 Floriana Costanzo1 Kliniken Beelitz GmbH1 Paolo Milani1 Hellenic Institute for the Study of Sepsis1 Esteve Pharmaceuticals, S.A.1 Marianna Adamo1 Central Hospital, Nancy, France1 San Rocco Therapeutics1 St. Anna Kinderkrebsforschung1 Endospan Ltd.1 Società Italiana di Endocrinologia e Diabetologia Pediatrica1 LIFE - Research and Care Institute - Santa Lucia IRCCS1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 Prescient Therapeutics, Ltd.1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 303 Pharma s.r.l.1 Emalex Biosciences Inc.1 Istituto Zooprofilattico Sperimentale delle Venezie1 PTC Therapeutics1 Hospital Clinico Universitario de Santiago1 Alessandra Gorini1 PedNet Haemophilia Research Foundation1 Medtronic Neurovascular Clinical Affairs1 Pietro Mortini, MD, Prof.1 Uptake Medical Technology, Inc.1 Laboratorio Farmaceutico SIT srl1 Calluna Pharma AS1 NTC srl1 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 Intellia Therapeutics1 Gesynta Pharma AB1 Santa Maria Hospital - GVM Care & Research1 AVEO Pharmaceuticals, Inc.1 Infectopharm Arzneimittel GmbH1 Khondrion BV1 Azienda Ospedaliera Universitaria Policlinico "G. Martino"1 Newcastle University1 Carmelo Chisari1 KU Leuven1 Tobias Feuchtinger1 Cristina Mussini1 Napo Therapeutics, S.p.A.1 Guardant Health, Inc.1 University of Patras1 Medtronic MiniMed, Inc.1 Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS1 Flavolife Srl1 Azienda Sanitaria Locale di Alessandria1 National Institute of Allergy and Infectious Diseases (NIAID)1 University of Dublin, Trinity College1 Iambic Therapeutics, Inc1 Bioprojet1 Silvia Benemei1 Tenaya Therapeutics1 Phenox GmbH1 Liquidia Technologies, Inc.1 Medstar Health Research Institute1 Prothya Biosolutions1 Xingshun Qi1 Enterome1 University of Belgrade1 Poznan University of Medical Sciences1 Vall d'Hebron Institute of Oncology1 Centro di Innovazione Regionale in Single Molecule Digital Assay1 Fondazione Michelangelo1 Société Internationale d'Urologie1 ASL Città di Torino1 SIFI SpA1 Buda Health Center1 Inmunova S.A.1 Astellas Gene Therapies1 Valo Therapeutics Oy1 PMV Pharmaceuticals, Inc1 Bellicum Pharmaceuticals1 Inotrem1 AllRock Bio, Inc.1 Massimiliano Bortolini1 Cardiac Dimensions, Inc.1 Menarini Group1 University of Padova, School of Dental Medicine1 Colorado State University1 Hospital Las Higueras1 Giampaolo Bianchini1 University of Cyprus1 icometrix1 Hospital Universitario 12 de Octubre1 San Giovanni Addolorata Hospital1 University of Genova1 Acrivon Therapeutics1 Impulse Dynamics1 Tecnologico de Monterrey1 Gianmarco de Donato1 Shenzhen Core Medical Technology CO.,LTD.1 Advanced Bionics AG1 DeepTrace Technologies S.r.l.1 Multidisciplinary Italian Study group for STOmas (MISSTO)1 Xynomic Pharmaceuticals, Inc.1 Incyte Biosciences Italy S.r.l1 River 2 Renal Corp.1 Wuerzburg University Hospital1 Ospedale San Pio1 Fundacio Puigvert1 U.G.A. Nutraceuticals1 Priovant Therapeutics, Inc.1 Upstream Bio Inc.1 Fin-Ceramica Faenza Spa1 Microbiotica Ltd1 Spanish Oncology Genito-Urinary Group1 GT Metabolic Solutions, Inc.1 Prof. Dr. med. Ingo Eitel1 Casper Rokx1 Pasquale Arpaia1 IO Biotech1 Day One Biopharmaceuticals, Inc.1 Generate Biomedicines1 Associazione Rete Italiana Mastocitosi1 Forma Therapeutics, Inc.1 Gianni Soraru1 Molnlycke Health Care AB1 Advanced Accelerator Applications1 Centre hospitalier de l'Université de Montréal (CHUM)1 piero portincasa1 Vega Therapeutics, Inc1 Marc van Sambeek1 Lionhealth Srl Società Benefit1 International CTEPH Association1 Università degli Studi dell'Aquila1 Matteo Santoni1 Policlinic Hospital "G. Rodolico"1 Dr. Schär AG / SPA1 Akcea Therapeutics1 Inna Chen, MD1 Zoll Medical Corporation1 Italian Academy of Rhinology1 Industrial Farmacéutica Cantabria, S.A.1 Biohaven Pharmaceuticals, Inc.1 Associazione Italiana Infermieri di Area Oncologica1 Toralf Reimer, MD PhD1 Italian Institute of Telemedicine1 Inventiva Pharma1 Centre Hospitalier Universitaire de Nice1 CanariaBio Inc.1 University Hospital Freiburg1 Apollomics Inc.1 CHA University1 B.Braun Avitum AG1 Prelude Therapeutics Incorporated1 German CLL Study Group1 Matteo's Friends1 BioAegis Therapeutics Inc.1 Azienda Sanitaria Universitaria Friuli Centrale1 Newronika1 Axon srl1 Pierre Fabre Dermo Cosmetique1 Fondazione Schena1 Direzione centrale salute, politiche sociali e disabilità1 Prof. Valérie Mc Lin1 Hopital Foch1 Ottawa Heart Institute Research Corporation1 Redx Pharma Ltd1 Dr. Rebecca Schule1 Endeavor Biomedicines, Inc.1 Azienda USL Toscana Centro1 Epygon1 Claudio Pedone1 University Hospital, Grenoble1 San Raffaele Telematic University1 Università Cattolica di Milano1 St. Antonius Hospital1 Guilherme Sant'Anna, MD1 Marta Mondellini1 S.M. Misericordia Hospital1 Ocus Innovation Ireland Limited1 Azienda Ospedaliera Brotzu1 Proed, Torino, Italy1 Fondazione Andrea Cesalpino Arezzo ONLUS1 Humanitas Hospital, Italy1 Voll Medical Technologies Ltd.1 Institute Franci1 CStone Pharmaceuticals1 Philips Clinical & Medical Affairs Global1 Shanghai Junshi Bioscience Co., Ltd.1 Azienda Ospedaliera di Lecco1 AC.TA. S.r.l.1 Michael Shy1 Mario Musella MD1 Baxalta now part of Shire1 Neuron23 Inc.1 ABResearch S.r.l.1 BioCryst Pharmaceuticals1 Antonio Pierini1 Global D1 GLORIA FIORAVANTI1 Galderma R&D1 Morrow Eyewear1 Swiss Cancer Institute1 University of Edinburgh1 Royal College of Surgeons, Ireland1 Candiolo Cancer Institute - IRCCS1 EXO Biologics S.A.1 ANRS, Emerging Infectious Diseases1 Italian Association for the Research and the Scientific Update1 Activ'inside1 Nicola Pagnucci1 Alessandro Micarelli1 Ugo Pastorino1 Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital1 Paola Pisani1 Cardionovum GmbH1 B&B srl1 Laminar Pharmaceuticals1 University Medical Center Nijmegen1 Martina Stefanini1 Azienda USL Toscana Nord Ovest1 Universidad Complutense de Madrid1 Danish Multiple Sclerosis Hospitals1 Partner Therapeutics, Inc.1 Italian Head&Neck Society1 Altheia Science1 Contego Medical, Inc.1 Implantica CE Reflux Ltd.1 St. Olavs Hospital1 Imbria Pharmaceuticals, Inc.1 NewAmsterdam Pharma1 University of Naples1 Joel Pollet1 Galimedix Therapeutics Inc1 Maddalena Casale1 Laterza Lucrezia1 University of Kansas Medical Center1 Vividion Therapeutics, Inc.1 Evergreen General Hospital, Taiwan1 Associazione Angela Serra per la ricerca sul cancro1 Friedreich's Ataxia Research Alliance1 Riccardo Guglielmo1 Sara Poletti1 Vor Biopharma1 Jules Bordet Institute1 Humanitas University1 Verici Dx1 Shanghai MicroPort CardioFlow Medtech Co., Ltd.1 Harmony Biosciences Management, Inc.1 Cardurion Pharmaceuticals, Inc.1 Quetzal Therapeutics1 Surgimab1 Deepull Diagnostics S.L.1 Paolo Pastori, MD1 SafeHeal Inc1 Antonio Molina Lopez1 Orchestra BioMed, Inc1 Curium US LLC1 Cardiovascular and Interventional Radiological Society of Europe1 ASST Gaetano Pini-CTO1 Annexon, Inc.1 Ethicon Endo-Surgery1 Stealth BioTherapeutics Inc.1 Electra Therapeutics Inc.1 MapLight Therapeutics1 Exactech1 Incyte Biosciences International Sàrl1 Ichnos Sciences SA1 Associazione Qol-one1 Bruno Bombaci1 Urteste S.A1 Chiesi Italia1 CytoSorbents, Inc1 Tobias Todsen1 HistoSonics, Inc.1 EBR Systems, Inc.1 Ryvu Therapeutics SA1 Indiana University1 Dr. Franco Molteni1 Prof. Andrea Kahlberg1 Xcovery Holdings, Inc.1 OHB Neonatology Ltd.1 Nerviano Medical Sciences1 IDRX, Inc., a wholly owned subsidiary of GSK, LLC1 Phost'In Therapeutics1 ThrombUS+1 Can-Fite BioPharma1 NYU Langone Health1 Tampere University1 Vectorious Medical Technologies Ltd.1 Ospedale Cottolengo1 Synthekine1 Lexicon Pharmaceuticals1 Orthofix s.r.l.1 Elion Therapeutics, Inc.1 University of Zurich1 Marco Oderda1 Imago 7 Fondazione di Ricerca onlus1 KardioVis S.r.l.1 Giuseppe Procopio1 Elixir Medical Corporation1 DiaSorin Inc.1 Royal Brompton & Harefield NHS Foundation Trust1 Albano Luigi1 Lexeo Therapeutics1 Pulmonx Corporation1 Immunome, Inc.1 Intuitive Surgical1 Antonello Di Paolo, M.D., Ph.D.1 Studio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo1 Xenothera SAS1 Cyprus Institute of Neurology and Genetics1 Crescent Biopharma, Inc.1 DePuy Orthopaedics1 King's College London1 Tenax Therapeutics, Inc.1 Priothera SAS1 Antonella Costantino1 Centervue SpA1 Permedica spa1 Coloplast A/S1 Biokosmes Srl1 Replimune, Inc.1 Relief srl1 AO Innovation Translation Center1 ALPFA Medical1 Rijnstate Hospital1 Micro Medical Solution, Inc.1 Tyra Biosciences, Inc1 Douglas D. Fraser1 Napo Pharmaceuticals, Inc.1 Nisha Acharya1 Prometei Pain Rehabilitation Center1 Solid Biosciences Inc.1 iTeos Therapeutics1 Laura Maria Vergani1 Nordberg Medical Italy srl1 Omikron Italia S.r.l.1 Ospedale Santa Croce-Carle Cuneo1 ASST Santi Paolo e Carlo1 Azienda Sanitaria-Universitaria Integrata di Udine1 University of Aarhus1 University of Virginia1 Heinrich-Heine University, Duesseldorf1 Joan Sabater-Riera1 Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares1 Pulmovant, Inc.1 Francesca Pistoia1 Centre Hospitalier Universitaire Vaudois1 Aura Biosciences1 Francesco Maisano1 MoonLake Immunotherapeutics AG1 Martin Schrappe1 ICE S.p.A.1 R3 Vascular Inc.1 Silence Therapeutics plc1 Bold Therapeutics, Inc.1 VarmX B.V.1 Kyowa Kirin, Inc.1 BeiGene1 Hasselt University1 4D Molecular Therapeutics1 University of Ulm1 AgNovos Healthcare, LLC1 University Hospital, Tours1 AusperBio Therapeutics Inc.1 Puerta de Hierro University Hospital1 American Heart of Poland1 Hamilton Health Sciences Corporation1 Johan Virhammar1 Alleviant Medical, Inc.1 dr. M.J.N.L. Benders1 Acrotech Biopharma Inc.1 Federation of Italian Cooperative Oncology Groups1 Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company1 Fundacao Champalimaud1 European EGPA Study Group1 Mediar Therapeutics1 Cardiovalve Ltd.1 Fore Biotherapeutics1 Armando Santoro, MD1 Kymera Therapeutics, Inc.1 Nordic Lymphoma Group1 Aron Research Foundation Ets1 Rapamycin Holdings Inc.1 Artiva Biotherapeutics, Inc.1 Lorenza Driul1 TORL Biotherapeutics, LLC1 Mineralys Therapeutics Inc.1 Fundacio Clinic Barcelona1 Eleonora Nucera1 Angelina Passaro1 PENTA Foundation1 CNS Pharmaceuticals, Inc.1 Nitinotes Surgical Ltd.1 DualityBio Inc.1 Creo Medical Limited1 Angela Toss1 Fiammetta Cosci1 Ottawa Hospital Research Institute1 Centro Cardiopatici Toscani1 AAVantgarde Bio Srl1 Odense University Hospital1 Ivy Brain Tumor Center1 Michael J. Fox Foundation for Parkinson's Research1 Teknimed1 Melanoma and Skin Cancer Trials Limited1 Innovacell GmbH1 European Breast Cancer Research Association of Surgical Trialists1 Solstice Oncology, Inc.1 Apellis Pharmaceuticals, Inc.1 GBG Forschungs GmbH1 JOTEC GmbH1 Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD1 Abcentra1 Institute of Cancer Research, United Kingdom1 Paolo Corradini1 Javier P. Gisbert1 Laura Deborah Locati1 Smith & Nephew Pte Ltd1 Stimuli Technology1 Valentina Micheluzzi1 Azienda Ospedaliero Universitaria di Cagliari1 BioLineRx, Ltd.1 Vaderis Therapeutics AG1 PPM Services S.A.1 Marco Emilio Bianchi1 Città di Lecce Hospital, GVM Care & Research1 Iksuda Therapeutics Ltd.1 MediWound Ltd1 EMN Trial Office S.r.l. Impresa Sociale1 Jiangsu HengRui Medicine Co., Ltd.1 FIAB SpA1 Iacopo Sardi1 SymBio Pharmaceuticals1 Byondis B.V.1 Villa Garda Hospital1 C.O.T. Cure Ortopediche Traumatologiche S.p.A.1 Corcym S.r.l1 Mitera Hospital1 Institute of Molecular and Clinical Ophthalmology Basel1 ImmunAbs Inc.1 SK Life Science, Inc.1 Kahramanmaras Sutcu Imam University1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 University of Massachusetts, Worcester1 Genexine, Inc.1 Cartesian Therapeutics1 NMD Pharma A/S1 ROELMI HPC1 Azienda USL Modena1 AventaMed DAC1 FB Vision S.p.A1 Shockwave Medical, Inc.1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Protagonist Therapeutics, Inc.1 University Children's Hospital, Zurich1 Treviso Regional Hospital1 Norgine1 NovoCure Ltd.1 Ferrer Internacional S.A.1 BellaSeno GmbH1 Hidde van der Ploeg1 Azienda Socio Sanitaria Territoriale di Lecco1 Fondazione ISIDE1 Savara Inc.1 Cardiol Therapeutics Inc.1 DigitalRehab1 Claudia Guerrieri1 Colospan Ltd.1 OncoHost Ltd.1 Advenchen Laboratories, LLC1 Erasca, Inc.1 CNS Onlus1 Rigel Pharmaceuticals1 Vicore Pharma AB1 North Eastern German Society of Gynaecological Oncology1 Magnus Nilsson1 Regional Hospital of Bolzano1 Leal Therapeutics, Inc1 PSC Partners Seeking a Cure1 Vedanta Biosciences, Inc.1 PhoenixLAB srls1 Synbalance S.r.l.1 Manuel Monreal1 Exciva GmbH1 Ambra Bisio1 DEO NV1 Bicara Therapeutics1 Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 Novartis Gene Therapies1 Schrödinger, Inc.1 Immutep S.A.S.1 TransThera Sciences (Nanjing), Inc.1 Universität des Saarlandes1 MicuRx1 Ancora Heart, Inc.1 Cardiochirurgia E.H.1 BetaGlue Therapeutics SpA1 ALX Oncology Inc.1 Norwegian University of Science and Technology1 X4 Pharmaceuticals1 Debiopharm International SA1 AviadoBio Ltd1 Policlinico Universitario, Catania1 Tensive SRL1 SCHETTINI SERGIO1 Weizmann Institute of Science1 Aqua Therapeutics, Inc.1 CVRx, Inc.1 Imperial College London1 Research Maatschap Cardiologen Rotterdam Zuid1 Monica Boitano1 Diakonhjemmet Hospital1 Aurel Mengri1 C4 Therapeutics, Inc.1 Powerful Medical1 Ricerca Nefrocenter1 Parma University Hospital1 Checkmab S.r.l.1 Children's Hospital Los Angeles1 IRCCS Istituto delle Scienze Neurologiche di Bologna1 Ascendis Pharma Oncology Division A/S1 Anthos Therapeutics, Inc.1 Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz1 Bial - Portela C S.A.1 UCB BIOSCIENCES, Inc.1 Amore Filippo1 Greenwich LifeSciences, Inc.1 Groupe SEBBIN1 The Cleveland Clinic1 InnovHeart1 Viatris Innovation GmbH1 Corxel Pharmaceuticals1 Instituto de Investigación Hospital Universitario La Paz1 Loulou Foundation1 Gelscom SAS1 Tanabe Pharma America, Inc.1 Eodyne Systems SL1 Mundipharma Research Limited1 Nicola Alberto Valente, DDS, MS, PhD1 Portal Therapeutics, Inc.1 CMR Surgical Ltd1 ProQR Therapeutics1 Zydus Therapeutics Inc.1 QED Therapeutics, a BridgeBio company1 Calico Life Sciences LLC1 Centre for Medical Sciences1 Uniter Onlus1 SoniVie Inc.1 OncoC4, Inc.1 Change Accelerator in Respiratory Care1 4bases Italia Srl1 AB Science1 Robocath1 Biosensors Europe SA1 Vastra Gotaland Region1 CDR-Life AG1 Acesion Pharma1 IHF GmbH - Institut für Herzinfarktforschung1 Agenus Inc.1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 OncoSil Medical Limited1 Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva1 Airway Therapeutics, Inc.1 Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1 Shanghai Argo Biopharmaceutical Co., Ltd.1 Philipp Dutkowski1 Monaldi Hospital1 Rotundo Roberto1 Agenzia di Tutela della Salute della Città Metropolitana di Milano1 HUYABIO International, LLC.1 Vifor Pharma, Inc.1 FzioMed1 European Society of Cardiology1 Anna Estraneo1 Azienda Sanitaria di Firenze1 Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI)1 DJO UK Ltd1 Policlinico di Monza SpA1 Valerio Nardone1 Faron Pharmaceuticals Ltd1 Fabrizio Faina1 TriFlo Cardiovascular, Inc.1 Valentina Cerrone1 ARTHEx Biotech S.L.1 Gemelli Molise Hospital1 Francesca Cecchi1 Centre Leon Berard1 University of Miami1 Sarcoma Alliance for Research through Collaboration1 IntraBio Inc1 ParVation Therapeutics, Inc.1 Glaukos Corporation1 The Leeds Teaching Hospitals NHS Trust1 Adamas Biotech S.r.l.1 Queensland Centre for Gynaecological Cancer1 Disc Medicine, Inc1 OncoVerity, Inc.1 Wim Janssens1 Gossamer Bio USA, Inc.1 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University1 The European Forum for Research and Education in Allergy and Airway Diseases1 Rna Diagnostics Inc.1 Stanford University1 Raffaele De Caterina1 Ferring Pharmaceuticals1 Intergruppo Melanoma Italiano1 Eurosets S.r.l.1 NVT GmbH1 Womed1 AlgoTherapeutix1 Gruppo Oncologico Italia Meridionale1 Dott.Claudio Sini1 Fondazione Valter Longo1 Zealand Pharma1 NORCE Norwegian Research Centre AS1 Fundación para la Investigación Biosanitaria del Principado de Asturias1 OnKure, Inc.1 Italian Society of Vascular and Endovascular Surgery1 Institut National de la Santé Et de la Recherche Médicale, France1 Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Jvan Casarin, MD PhD1 Noema Pharma AG1 Benedetto Falsini1 Nouscom SRL1 SecuraBio1 Raffaele Marfella1 Hemab ApS1 Nuvation Bio Inc.1 Centre Hospitalier Universitaire de Besancon1 Amsterdam UMC1 Stryker Neurovascular1 Amryt Pharma1 Marco Mazzola1 The Hospital for Sick Children1 Pharmanutra S.p.a.1 Anika Therapeutics, Inc.1 AGO Study Group1 Ospedale V. Fazzi1 Alessio Fasano1 Matteo Clavarezza1 Thena Biotech S.r.l.1 Massimo Falconi1 Federico Cappuzzo1 Melanoma Institute Australia1 University of Rome G. Marconi1 Taumedika s.r.l.1 GCP-Service International West GmbH1 Andreas Guenther1 The University of Texas Health Science Center, Houston1 Cleveland Clinic London1 Arbor Research Collaborative for Health1 National Eye Institute (NEI)1 Smith & Nephew Orthopaedics AG1 Bioverativ, a Sanofi company1 Valeria Cento1 ULSS6 - Ospedale di Piove di Sacco1 Blue Earth Diagnostics1 Certmedica International GmbH1 Nobles Medical Technologies II Inc1 Fondazione ICONA1 Lipogems International spa1 Matthias Stuber1 University Hospital of Cologne1 Bordeaux Colorectal Institute1 Rottapharm Biotech1 University College Cork1 University of Applied Sciences and Arts of Southern Switzerland1 Medical University of Silesia1 Oncology Institute of Southern Switzerland1 Italian Association Neuroendocrine Tumors1 Vittore Buzzi Children's Hospital1 Aligos Therapeutics1 Zogenix, Inc.1 Venus MedTech (HangZhou) Inc.1 LeonaBio1 SpliSense Ltd.1 Saint Camillus International University of Health Sciences1 pharmaand GmbH1 Cerevance1 Institut Straumann AG1 Cochlear1 Fondazione San Giuliano Onlus1 Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne1 Julius Clinical1 HiFiBiO Therapeutics1 Enea Parimbelli1 Tourmaline Bio, Inc., a Novartis Company1 Dimerix Bioscience Pty Ltd1 Breast Cancer Trials, Australia and New Zealand1 Recornea Srl1 Hospices Civils de Lyon1 Shanghai Henlius Biotech1 Alliance for Clinical Trials in Oncology1 Eastern Virginia Medical School1 Moleculin Biotech, Inc.1 Fisiopoint Parma Physiotherapy1 Palisade Bio1 AriBio Co., Ltd.1 Leonardo Calò, MD1 Wockhardt1 Ospedale Edoardo Bassini1 Inari Medical1 Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro1 IGLESIAS Juan Fernando1 EspeRare Foundation1 Marco Lorenzo Bonu1 Telethon Kids Institute1 Zai Lab (Shanghai) Co., Ltd.1 The Netherlands Cancer Institute1 SAb Biotherapeutics, Inc.1 Danone Nutricia SpA Società Benefit1 Contura1 Azienda Sanitaria Locale di Asti1 Minneapolis Heart Institute Foundation1 San Carlo Public Hospital, Potenza, Italy1 GERCOR - Multidisciplinary Oncology Cooperative Group1 Frank G. Holz1 Ospedali Riuniti Ancona1 Rarecells Diagnostics SAS1 Exact Sciences Corporation1 University of Manchester1 Kyowa Kirin Pharmaceutical Development Ltd1 MediLink Therapeutics (Suzhou) Co., Ltd.1 EIR Biotherapies s.r.l.1 SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 Helsinki University Central Hospital1 Carmen Concerto1 ITAB - Institute for Advanced Biomedical Technologies1 Prof. Dr. Matthis Synofzik1 Science Corporation1 Brigham and Women's Hospital1 Wissenschaftliches Institut Bethanien e.V1 Camurus AB1 CarThera1 Marina Coletta1 Augusto Caraceni1 Stoke Therapeutics, Inc1 Istituto Italiano di Tecnologia1 Imagine Institute1 Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo1 Pulse Biosciences, Inc.1 University Hospital, Montpellier1 Giovanni Di Perri1 Oculox Technologies SA1 Inhibikase Therapeutics1 Sun Pharmaceutical Industries Limited1 Cabaletta Bio1 University Hospital, Gasthuisberg1 GUALTIERO PALARETI1 Emanuele Barabino1 Telios Pharma, Inc.1 Institut Claudius Regaud1 University of South Florida1 GUIDO CAMANNI1 University of Michigan1 VU University of Amsterdam1 Elisa Giannetta1 Paolo Giorgio Arcidiacono, MD1 Azienda Ospedaliera Universitaria Senese1 Research Center Borstel1 Epizyme, Inc.1 Dr. Yaroslav Winter1 INNODIA iVZW1 University of Eastern Piedmont1 Genethon1 Hedera Dx SA1 Reprieve Cardiovascular, Inc1 Uniquity One (UNI)1 Montefiore Medical Center1 XVIVO Perfusion1 Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd1 Istituto di Neuroscienze Consiglio Nazionale delle Ricerche1 Target PharmaSolutions, Inc.1 Y-mAbs Therapeutics1 Sunnybrook Health Sciences Centre1 Società Scientifica di Psicoterapia Strategica1 Eclipse Medical Ltd.1 CHDI Foundation, Inc.1 Clear sponsor filter
Site location
Milan76 Rome72 Naples46 Genoa26 Bologna20 Meldola18 Bergamo18 Brescia18 Bari16 Florence14 Palermo13 Pavia13 Turin13 Rozzano12 Modena10 Padova9 Parma8 Orbassano8 Perugia8 Pisa7 Chieti7 Monza6 Novara6 Catania6 Ravenna6 Foggia5 Roma5 Aviano5 Pozzilli4 Reggio Emilia4 Verona4 Catanzaro4 Montichiari3 Torrette - Ancona3 Avellino3 Trieste3 Ancona3 Salerno3 Rozzano (MI)3 Misterbianco (CT)3 Cona (Ferrara)2 Gallarate2 Cefalù2 Cremona2 Livorno2 Bagno a Ripoli2 Monza MI2 Rho2 San Donato Milanese (MI)2 Negrar2 Tricase (LE)2 Caserta2 Aviano (PN)2 Udine2 Alessandria2 Matera2 Sassari1 Terni1 Napoli1 Castelfranco Veneto1 Ponderano1 Mondovì (CN)1 Sant'Andrea Delle Fratte (PG)1 Siena1 Taranto1 Reggio Calabria1 Pozzilli (IS)1 Lecce1 Torrette Di Ancona1 Candiolo1 Cona, Ferrara1 Magnago1 Statte1 Pesaro1 Cassino1 Brindisi1 Rimini1 Tricase1 Peschiera Del Garda (VR)1
All 79 locations
Target enrolment
to

Trials in this register

106 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Hoffmann-La Roche
Phase 3
400
Rome, Bergamo, Milan, Florence, Perugia, Peschiera Del Garda (VR)
2026-10-06
Recruiting
Hoffmann-La Roche
Phase 3
380
Bologna, Meldola, Rome, Bergamo, Rozzano, Turin
2026-06-23
Recruiting
Hoffmann-La Roche
Phase 2
30
Rome, Brescia, Rozzano
2026-05-25
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Naples, Meldola, Modena, Parma, Aviano, Rome, Bergamo, Brescia
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 3
138
Naples, Milan, Rozzano, Florence
2026-05-15
Recruiting
Hoffmann-La Roche
Phase 3
8
Rome, Pavia
2026-05-06
Recruiting
Hoffmann-La Roche
Phase 3
360
Naples, Milan, Rozzano, Florence
2026-04-27
Recruiting
Hoffmann-La Roche
Phase 2
80
Naples, Meldola, Rome, Bergamo, Milan
2026-04-07
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Bergamo, Catanzaro, Bologna, Rome, Milan, Palermo, Perugia
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bergamo, Bari, Catanzaro, Bologna, Rome, San Donato Milanese (MI), Palermo, Pisa
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 2
100
Rome, Milan, Castelfranco Veneto
2026-03-11
Recruiting
Hoffmann-La Roche
Phase 2
360
Chieti, Naples, Salerno, Roma, Genoa, Milan, Pavia
2026-03-10
Active, closed
Hoffmann-La Roche
Phase 2
120
Rome, Ancona
2026-01-08
Recruiting
Hoffmann-La Roche
Phase 2
160
Reggio Emilia, Rome, Rozzano
2025-12-05
Recruiting
Hoffmann-La Roche
Phase 3
250
Naples, Cona (Ferrara), Rome, Milan, Novara, Turin, Palermo
2025-11-27
Recruiting
Hoffmann-La Roche
Phase 3
900
Naples, Salerno, Bologna, Cassino, Rome, Genoa, Brescia, Milan
2025-11-24
Active, closed
Hoffmann-La Roche
Phase 2
193
Foggia, Naples, Rome, Milan, Pozzilli
2025-11-13
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Naples, Modena, Rome, Perugia
2025-11-12
Recruiting
Hoffmann-La Roche
Phase 3
600
Statte, Naples, Modena, Pesaro, Aviano, Rome, Genoa, Milan
2025-10-24
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Rome, Genoa, Brescia, Milan
2025-09-17
Recruiting
Hoffmann-La Roche
Observational
700
Lecce, Naples, Modena, Ravenna, Rome, Genoa, Bergamo, Milan
2025-07-15
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Naples, Rome, Genoa, Brescia, Milan, Palermo, Perugia
2025-07-02
Recruiting
Hoffmann-La Roche
Phase 3
75
Rome, Milan, Florence
2025-06-27
Recruiting
Hoffmann-La Roche
Phase 3
425
Matera, Bologna, Rome, Brescia, Milan, San Donato Milanese (MI), Negrar
2025-05-12
Active, closed
Hoffmann-La Roche
Observational
44
Rome, Milan, Florence
2025-04-29
Recruiting
Hoffmann-La Roche
Phase 3
450
Tricase (LE), Caserta, Naples, Bologna, Meldola, Modena, Rome, Bergamo
2025-04-09
Active, closed
Hoffmann-La Roche
Phase 2
30
Rome, Milan
2025-04-04
Active, closed
Hoffmann-La Roche
Phase 2
162
Roma, Milan, Catania, Ancona
2025-04-01
Recruiting
Hoffmann-La Roche
Phase 3
600
Bari, Catanzaro, Naples, Rome, Milan, Monza MI, Pavia, Rho
2025-03-17
Active, closed
Hoffmann-La Roche
Phase 4
274
Foggia, Rome, Milan, Napoli, Torrette - Ancona
2025-03-14
Recruiting
Hoffmann-La Roche
Phase 2
130
Naples, Meldola, Brescia, Milan, Rozzano
2025-03-05
Active, closed
Hoffmann-La Roche
Phase 3
350
Rome, Brescia, Milan, Monza MI, Rozzano (MI), Negrar
2024-12-11
Active, closed
Hoffmann-La Roche
Phase 2
62
Bari, Rome, Orbassano, Verona
2024-12-09
Active, closed
Hoffmann-La Roche
Phase 3
338
Bari, Parma, Rome, Genoa, Sassari, Florence, Pisa, Padova
2024-09-23
Active, closed
Hoffmann-La Roche
Phase 3
400
Matera, Naples, Rome, Pavia, Rho
2024-09-17
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Bergamo, Foggia, Milan, Novara, Palermo, Roma, Rome, Rozzano
2024-05-24
Active, closed
Hoffmann-La Roche
Phase 2
256
Tricase (LE), Rome, Milan, Pavia
2024-05-02
Recruiting
Hoffmann-La Roche
Phase 4
320
Meldola, Modena, Aviano (PN), Rome, Milan
2024-04-02
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,350
Bergamo, Foggia, Milan, Modena, Naples, Novara, Palermo, Roma
2024-03-13
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Brindisi, Avellino, Naples, Bologna, Meldola, Parma, Aviano (PN), Udine
2023-12-11
Active, closed
Hoffmann-La Roche
Phase 2
13
Rome
2023-11-29
Recruiting
Hoffmann-La Roche
Phase 3
182
Bologna, Bergamo, Milan, Alessandria, Turin
2023-10-22
Recruiting
Hoffmann-La Roche
Phase 1/2
60
Milan, Rozzano (MI)
2023-09-21
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Naples, Bologna, Modena, Genoa, Bergamo, Milan, Rozzano, Catania
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
687
Tricase, Bologna, Rome, Genoa, Rozzano, Palermo, Verona
2023-09-14
Recruiting
Hoffmann-La Roche
Phase 3
230
Meldola, Rome, Milan, Monza, Novara, Palermo, Bagno a Ripoli, Verona
2023-09-08
Active, closed
Hoffmann-La Roche
Phase 3
459
Bari, Naples, Bologna, Genoa, Pavia, Turin
2023-08-08
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Naples, Cona, Ferrara, Pavia, Catania, Palermo
2023-06-28
Recruiting
Hoffmann-La Roche
Phase 1/2
320
Naples, Rome, Milan, Orbassano
2023-06-20
Recruiting
Hoffmann-La Roche
Phase 3
420
Caserta, Meldola, Ravenna, Aviano, Milan, Alessandria, Turin, Misterbianco (CT)
2023-06-07
Active, closed
Hoffmann-La Roche
Phase 2
204
Bari, Naples, Bologna, Meldola, Rome, Milan, Terni, Padova
2023-04-13
Active, closed
Hoffmann-La Roche
Phase 2
301
Bologna, Rome, Milan
2023-02-03
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Chieti, Bari, Catanzaro, Naples, Udine, Rome, Genoa, Bergamo
2022-11-21
Recruiting
Hoffmann-La Roche
Phase 1/2
65
Rome, Turin
2022-11-16
Active, closed
Hoffmann-La Roche
Phase 3
68
Meldola, Milan
2022-11-01
Active, closed
Hoffmann-La Roche
Phase 1
121
Bologna, Meldola, Pisa
2022-10-26
Active, closed
Hoffmann-La Roche
Phase 1/2
90
Bologna, Bergamo, Milan, Turin
2022-10-17
Active, closed
Hoffmann-La Roche
Phase 3
122
Naples, Genoa, Pavia, Palermo
2022-09-27
Active, closed
Hoffmann-La Roche
Phase 3
139
Pavia, Orbassano, Verona
2022-08-30
Active, closed
Hoffmann-La Roche
Phase 3
922
Naples, Reggio Emilia, Rimini, Rome, Brescia, Milan, Rozzano, Misterbianco (CT)
2022-07-18
Active, closed
Hoffmann-La Roche
Phase 4
136
Rome, Milan, Florence
2022-06-20
Active, closed
Hoffmann-La Roche
Phase 3
188
Chieti, Bari, Rome, Milan, Catania
2022-05-19
Recruiting
Hoffmann-La Roche
Phase 2
40
Rome, Genoa, Milan
2022-05-12
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Gallarate, Ponderano, Rome, Genoa, Milan, Montichiari, Orbassano, Cefalù
2022-05-03
Recruiting
Hoffmann-La Roche
Phase 1
332
Brescia, Milan, Sant'Andrea Delle Fratte (PG)
2022-03-07
Active, closed
Hoffmann-La Roche
Phase 3
660
Ravenna, Genoa, Milan, Torrette Di Ancona
2021-11-18
Active, closed
Hoffmann-La Roche
Phase 3
478
Bologna, Ravenna, Palermo, Ancona, Florence, Padova
2021-10-27
Active, closed
Hoffmann-La Roche
Phase 3
303
Rome, Milan, Pisa, Cona (Ferrara), Padova
2021-10-26
Recruiting
Hoffmann-La Roche
Phase 1
542
Naples, Meldola, Rome, Milan, Padova
2021-10-22
Active, closed
Hoffmann-La Roche
Phase 3
83
Rome, Genoa
2021-10-22
Active, closed
Hoffmann-La Roche
Phase 2
176
Bari, Naples, Rome, Milan
2021-10-07
Active, closed
Hoffmann-La Roche
Phase 3
217
Rome, Genoa, Orbassano, Padova
2021-09-30
Active, closed
Hoffmann-La Roche
Phase 1/2
42
Genoa, Milan, Turin
2021-09-14
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Avellino, Naples, Bologna, Meldola, Reggio Emilia, Roma, Milan, Rozzano (MI)
2021-08-27
Active, closed
Hoffmann-La Roche
Phase 1
119
Milan
2021-08-11
Active, closed
Hoffmann-La Roche
Phase 3
451
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2021-07-14
Active, closed
Hoffmann-La Roche
Phase 3
142
Bari, Naples, Brescia, Monza, Turin
2021-06-25
Active, closed
Hoffmann-La Roche
Observational
800
Taranto, Reggio Calabria, Meldola, Rome, Genoa, Brescia, Cremona, Novara
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 2
586
Naples, Salerno, Bologna, Rome, Genoa, Brescia, Milan, Pozzilli (IS)
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Avellino, Naples, Modena, Aviano, Rome, Brescia, Milan, Livorno
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
557
Naples, Bologna, Rome, Milan, Turin, Palermo, Florence, Pisa
2021-04-26
Active, closed
Hoffmann-La Roche
Phase 3
751
Chieti, Bari, Naples, Rome, Genoa, Milan, Montichiari, Pavia
2021-03-24
Active, closed
Hoffmann-La Roche
Phase 3
746
Foggia, Naples, Parma, Rome, Bergamo, Milan, Mondovì (CN), Catania
2021-03-17
Active, closed
Hoffmann-La Roche
Phase 3
55
Naples, Parma, Milan, Florence
2021-02-04
Active, closed
Hoffmann-La Roche
Phase 2
920
Rome, Brescia, Milan, Turin, Siena
2021-01-18
Active, closed
Hoffmann-La Roche
Phase 3
769
Naples, Rome, Gallarate, Milan, Pavia, Turin
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
864
Chieti, Naples, Rome, Milan, Pozzilli
2020-11-26
Active, closed
Hoffmann-La Roche
Phase 3
985
Naples, Parma, Rome, Genoa, Milan, Montichiari, Pozzilli, Palermo
2020-10-26
Active, closed
Hoffmann-La Roche
Phase 3
992
Meldola, Rome, Brescia, Milan, Monza, Misterbianco (CT), Candiolo, Livorno
2020-10-09
Active, closed
Hoffmann-La Roche
Phase 3
190
Ravenna, Rome, Milan, Turin, Florence
2020-09-30
Active, closed
Hoffmann-La Roche
Phase 1/2
210
Parma, Bergamo, Magnago
2020-09-03
Active, closed
Hoffmann-La Roche
Phase 3
271
Bari, Genoa, Brescia, Florence, Padova
2020-08-10
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Parma, Brescia, Milan, Bagno a Ripoli, Padova
2020-01-29
Active, closed
Hoffmann-La Roche
Phase 2
23
Rome, Catania
2020-01-09
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Naples, Bergamo, Milan, Rozzano
2019-08-13
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Naples, Rome, Genoa, Milan, Pavia, Orbassano, Cefalù
2019-08-12
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Milan
2019-02-28
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2018-09-20
Active, closed
Hoffmann-La Roche
Phase 3
257
Naples, Rome, Milan, Orbassano, Perugia
2018-08-16
Active, closed
Hoffmann-La Roche
Phase 3
927
Bari, Naples, Trieste, Rome, Genoa, Milan, Pavia, Pozzilli
2018-05-28
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Naples, Meldola, Aviano, Rome, Bergamo, Cremona, Milan, Monza
2017-09-22
Active, closed
Hoffmann-La Roche
Phase 3
382
Naples, Modena, Rome, Genoa, Milan, Monza, Novara, Orbassano
2017-09-20
Active, closed
Hoffmann-La Roche
Phase 1/2
940
Ravenna, Milan, Rozzano
2017-02-21
Active, closed
Hoffmann-La Roche
Phase 1/2
69
Milan
2016-05-03
Active, closed
Hoffmann-La Roche
Phase 2
534
Naples, Rome, Milan, Pisa, Perugia, Padova
2015-11-19
Active, closed
Hoffmann-La Roche
Phase 3
154
Bari, Bologna, Meldola, Reggio Emilia, Milan, Monza, Pisa
2015-02-02
Rows per page Showing 1–106 of 106
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-italy

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 106 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Italy?

37 of the 106 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 69 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 106 studies
PhaseStudiesRecruitingShare
Phase 3622258.5%
Phase 221719.8%
Phase 1/2938.5%
Observational413.8%
Phase 1423.8%
Phase 2/3312.8%
Phase 4312.8%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Hoffmann-La Roche10637

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (7) Multiple Sclerosis (6) Non-Small Cell Lung Cancer (5) Solid Tumors (3) Hemophilia A (3) Alzheimers Disease (3) Lupus Nephritis (3) Multiple Sclerosis, Primary Progressive (2) KRAS G12C Lung Cancer (2) Duchenne Muscular Dystrophy (2) Von Willebrand Disease, Type 3 (2) Neovascular Age-related Macular Degeneration (nAMD) (2) Cancer (2) Relapsing Multiple Sclerosis (2) Neovascular Age-related Macular Degeneration (2)
→

Browse trials by site location

Milan (76) Rome (72) Naples (46) Genoa (26) Bologna (20) Meldola (18) Bergamo (18) Brescia (18) Bari (16) Florence (14) Palermo (13) Pavia (13) Turin (13) Rozzano (12) Modena (10)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.